EV/EBITDA:
10.84+0.08(+0.74%)Summary
- As of today, HALO EV/EBITDA is 10.84, with a rise of +0.08 (+0.74%) during the most recent trading session on October 31, 2025.
- Over the past year, HALO EV/EBITDA has dropped by -3.13 (-22.41%).
- HALO EV/EBITDA is now -99.66% below its all-time high of 3171.43.
Performance
HALO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
HALO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.7% | +0.8% | +0.9% |
| 1M1 Month | -4.9% | -4.9% | -5.5% |
| 3M3 Months | +9.2% | +9.2% | +10.4% |
| 6M6 Months | -8.0% | +3.5% | +6.5% |
| YTDYTD | +4.2% | +25.8% | +36.4% |
| 1Y1 Year | -22.4% | +5.9% | +14.1% |
| 5Y5 Years | -88.9% | +98.7% | +106.2% |
HALO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 11.40 | -11.7% | 10.68 | +1.5% |
| 3M | 3-Month | 12.78 | -15.2% | 9.93 | +9.2% |
| 6M | 6-Month | 13.34 | -18.7% | 8.94 | +21.3% |
| 1Y | 1-Year | 14.83 | -26.9% | 8.94 | +21.3% |
| 3Y | 3-Year | 31.91 | -66.0% | 8.94 | +21.3% |
| 5Y | 5-Year | 134.51 | -91.9% | 8.94 | +21.3% |
| All-Time | All-Time | 3171.43 | -99.7% | -205.45 | +105.3% |
HALO EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 10.84(+4.2%) |
| 2024 | 10.40(-19.6%) |
| 2023 | 12.94(-53.8%) |
| 2022 | 28.00(+28.0%) |
| 2021 | 21.87(-42.3%) |
| 2020 | 37.89(+189.1%) |
| 2019 | -42.53(-33.7%) |
| 2018 | -31.82(-203.9%) |
| 2017 | 30.62(+288.4%) |
| 2016 | -16.25(+80.9%) |
| Date | Value |
|---|---|
| 2015 | -85.29(-361.8%) |
| 2014 | -18.47(+13.9%) |
| 2013 | -21.46(-63.8%) |
| 2012 | -13.10(+73.9%) |
| 2011 | -50.13(-270.8%) |
| 2010 | -13.52(-70.3%) |
| 2008 | -7.94(+52.0%) |
| 2007 | -16.55(+50.1%) |
| 2006 | -33.19(-389.5%) |
| 2005 | -6.78 |
FAQ
- What is Halozyme Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Halozyme Therapeutics, Inc.?
- What is HALO EV/EBITDA year-to-date change?
- What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Halozyme Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of HALO is 10.84
What is the all-time high EV/EBITDA for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high EV/EBITDA is 3171.43
What is HALO EV/EBITDA year-to-date change?
Halozyme Therapeutics, Inc. EV/EBITDA has changed by +0.44 (+4.23%) since the beginning of the year
What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, HALO EV/EBITDA has changed by -3.13 (-22.41%)